stars 1 stars 2 stars 3

Our goal is to prevent cancer, extend survival rates, and improve quality of life for people with cancer Sentrimed is currently refining the production of drugs that specifically target malignant and metastatic cancer cells. This technology should fight the disease without the toxicity and collateral damage produced by conventional chemotherapy drugs. Copyright 2018 Sentrimed | All Rights Reserved. SentrimedĀ® and MASLĀ® are registered trademarks of Sentrimed.

Sentrimed Questions

The Sentrimed annual revenue was $4 million in 2026.

Sentrimed is based in Mullica Hill, New Jersey.

The NAICS codes for Sentrimed are [5417, 54, 541].

The SIC codes for Sentrimed are [87, 873].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users